HMRs
Boots scandal highlights benefits of pharmacist ownership
Managers at Boots, the UK’s biggest pharmacy chain, have been pressuring their pharmacists to abuse Medicine Use Reviews, providing them to patients who do not need them or cannot use …
Practice incentives for pharmacists in general practice: is it time to take the leap?
Manya Angley takes a look at the pharmacist role in general practice—and the road ahead The Australian Commission on Safety and Quality in Health Care (ACSQHC) concluded that 2%–3% of …
Medication reviews for people with intellectual disability
Medication reviews for people with intellectual disability are a key tool in addressing an access gap in an underserved population, writes Manya Angley The authors of a recent systematic review …
Do pharmacists work in silos?
Excluding pharmacists when their patients are hospitalised or enter other treatment settings causes nothing but trouble, writes Karalyn Huxhagen I recently attended the SHPA Summit in Melbourne and presented in …
It’s an exciting time to be in pharmacy: Amy Page
It’s an exciting time to be in pharmacy, says PSA Young Pharmacist of the Year 2015 Amy Page—and the profession now has the numbers to expand where it practices and …
Embrace professional services: Camden pharmacist
Forward pharmacy needs to be formally recognised in university pharmacy schools, and pharmacists given the tools to embrace professional services and counselling fully, says Bobby Afshari, owner of Blooms the …
PSA calls for review on medicines reviews caps
Several aspects of medication reviews should be reviewed, including the cap on services, says PSA president Joe Demarte. His comments followed the publication of a landmark study on the impact of …
Pharmacy needs clarity on rural, ATSI initiatives: Hannah Mann
Funding in the 6CPA for new and expanded pharmacy services focusing on rural and remote health, and Aboriginal and Torres Strait Islander health, are positive but pharmacies servicing these communities …
SHPA says 6CPA lacks detail, patient focus
The SHPA says it is concerned about the lack of detail and patient focus in the SIxth Community Pharmacy Agreement, including lack of clarity as to whether HMRs will remain …